Skip to content

Application of ultrasound-guided serratus anterior block in radical mastectomy for breast cancer

Application of ultrasound-guided serratus anterior block in radical mastectomy for breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065951
Enrollment
Unknown
Registered
2022-11-18
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group 1:Ultrasound-guided serratus anterior block

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Aged 18-75 years; 3. Elective unilateral breast cancer radical mastectomy under general anesthesia; 4. Voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to serratus anterior muscle block (allergic to the anesthetics used in this study, severe coagulation abnormality, abnormal platelet count, infection at the puncture site, etc.) or patients who refuse to accept nerve block, morbidly obese (BMI > 40 kg/m2) and high-risk patients with malignant hyperthermia; 2. Those with a history of mental and neurological diseases, alcohol and drug abuse, and long-term use of opioids or tranquilizers; 3. Patients with abnormal heart, lung, liver and kidney function; 4. Preoperative radiotherapy and chemotherapy, preoperative chronic pain, preoperative chronic pain, neuromuscular disease, pregnancy and simultaneous bilateral surgery; 5. Patients who cannot cooperate with this study due to some reasons (such as deafness, blindness, language and communication barriers, etc.).

Design outcomes

Primary

MeasureTime frame
Postoperative pain score;General information of the patient;

Secondary

MeasureTime frame
Anesthetic complications;

Countries

China

Contacts

Public ContactShi Jinghong

The First Affiliated Hospital of Chengdu Medical College

707475018@qq.com+86 18380736677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026